the webinar seems to be consistent with the presentation given by Auscann recently. Ido made is very clear that they won't be commercialising any novel drugs as this takes 10-15 years and $200m dollars. So this does leave the question if his plan is purely to create drug delivery technology of a "hard shell capsule", does this have any value?
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Investor Webinar Recording
Ann: AusCann Investor Webinar Recording, page-4
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online